Master Session: Uterine Cancer - Management of Endometrial Cancer in The Molecular Era
Chair(s)
Glauco Baiocchi (Brazil) Ramez N. Eskander (United States of America)Graziela Zibetti Dal Molin (Brazil)Jessica N. McAlpine (Canada)Mansoor R. Mirza (Denmark)
Moderated by Jessica N. McAlpine (Canada)
Should we avoid uterine manipulator in MIS for endometrial cancer?
Mario Leitao (USA)
Suspicious lymph node during sentinel node biopsy. Is there a role for systematic lymphadenectomy?
Emma C. Rossi (USA)
Should all ITC and micrometastasis receive adjuvant treatment?
Andrea Mariani (USA)
Can lymph node staging ± other surgical decisions be tailored in context molecular subtype?
Amy Jamieson (Canada)
PANEL 1 - DISCUSSION
Jessica N. McAlpine (Canada) Mario M. Leitao (USA) Emma C. Rossi (USA) Andrea Mariani (USA)Amy Jamieson (Canada)
PANEL 2: CONTROVERSIES IN ENDOMETRIAL CANCER
Moderated by Graziela Zibetti Dal Molin
How can I get molecular classification/subtyping for patients? Considerations for both low and high resource settings?
Naveena Singh (Canada)
DEBATE: What should be the best approach for endometrioid (grade 3) with small volume long term relapsed disease?
DEBATE: Pro for surgery
Nadeem R. Abu-Rustum (USA)
DEBATE: Pro for SBRT
Anuja Jhingran (USA)
DEBATE: Pro for systemic treatment
Domenica Lorusso (Italy)
Are we ready to incorporate molecular classification into clinical practice and treatment planning?
Shannon N. Westin (USA)
PANEL 2 - DISCUSSION
Graziela Zibetti Dal Molin (Brazil) Naveena Singh (Canada) Nadeem R. Abu-Rustum (USA) Anuja Jhingran (USA) Domenica Lorusso (Italy) Shannon N. Westin (USA)
PANEL 3: NEW TREATMENT OPTIONS FOR ADVANCED AND METASTATIC DISEASE
Moderated by Helen MacKay
Biomarkers in clinical practice for endometrial cancer: MMR status, TMB, PDL-1, TP53mut, ERpos, HER2+ : How can we improve outcomes?
Ana Oaknin (Spain)
What is the concept of platinum-resistance and platinum-free interval in endometrial cancer?
Vicky Makker (United States of America)
PANEL 3 - DISCUSSION
Helen J. MacKay (Canada) Ana Oaknin (Spain) Vicky Makker (USA)